Scott A. Gangloff insider trades
Open-market stock purchases and sales by Scott A. Gangloff, Chief Technology Officer at Akero Therapeutics, Inc, from SEC Form 4 filings since Nov 9, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | — |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | — |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $349K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $2.2M |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $4M |